Tag Archives: Tax Inversion

Mylan CEO Bent Truth About Epipen Profit; Sadly Follows Path of Valeant, Turing Pharma

Controversial Mylan NV (Amsterdam) CEO Heather Bresch was grilled in a marathon committee hearing about the EpiPen’s pricing before Congress last week. But it turns out that several of her… Read more »

Medtronic Buys HeartWare for $1.1 Billion

Medtronic PLC (Dublin) said it agreed to acquire HeartWare International Inc. (Framingham MA) for $1.1 billion, adding more heart-treatment products to the giant medical-device maker. Medtronic will pay $58 a share in cash for… Read more »

Pfizer Earnings Exceed Estimates; Company Raises 2016 Forecast

Pfizer Inc. (New York), which last month abandoned its $160 billion quest for Allergan PLC (Dublin IRL), reported quarterly results that blew past analysts’ estimates on sales of its new… Read more »

New Inversion Rules Test Pending Deals, WSJ Reports

The U.S. Treasury Department’s latest attempt at stopping corporate inversions last week spelled doom for Pfizer Inc.’s (New York City) $150 billion attempted takeover of Allergan PLC (Dublin IRL)–what would… Read more »